A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Postmenopausal Women With Breast Cancer
An Interventional, Open-Label, Randomized, Multicenter, Phase 2 Study of PF-07220060 Plus Letrozole Compared to Letrozole Alone in Postmenopausal Women 18 Years or Older With Hormone Receptor-Positive, HER2-Negative Breast Cancer in the Neoadjuvant Setting
Category & Conditions: Cancer
Medicine: PF-07220060
ClinicalTrials.gov Identifier (NCT): NCT06465368
Protocol ID: C4391025
Report Type: Final
Language: English
Open Plain Language Summary Result:
Click here